NRG
GSK icon

Nemes Rush Group’s GSK GSK Stock Holding History

Nemes Rush Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.4K Hold
188
– – ﹤0.01% 543
2025
Q4 		$9.22K Buy
188
+98
+109% +$4.57K ﹤0.01% 558
2025
Q3 		$3.88K Hold
90
– – ﹤0.01% 566
2025
Q2 		$3.46K Hold
90
– – ﹤0.01% 570
2025
Q1 		$3.49K Hold
90
– – ﹤0.01% 565
2024
Q4 		$3.04K Buy
+90
New +$3.24K ﹤0.01% 585
2024
Q2 		– Sell
-1,201
Closed -$51.5K – 635
2024
Q1 		$51.5K Hold
1,201
– – 0.01% 269
2023
Q4 		$44.5K Hold
1,201
– – 0.01% 267
2023
Q3 		$43.5K Sell
1,201
-150
-11% -$5.32K 0.01% 267
2023
Q2 		$48.1K Buy
+1,351
New +$48.5K 0.01% 267

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Nemes Rush Group's GSK Position: Q1 2026 in Review

Nemes Rush Group held its GSK (GSK) position steady in Q1 2026 at 188 shares worth $10.4K. The position accounts for ﹤0.01% of the portfolio, ranked #543.

Nemes Rush Group first reported a position in GSK in Q2 2023 and has held it in 10 quarters since. The position peaked at $51.5K in Q1 2024. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Nemes Rush Group held 188 shares of GSK worth $10.4K as of Q1 2026.
  • Nemes Rush Group left its GSK share count unchanged in Q1 2026.
  • GSK made up ﹤0.01% of Nemes Rush Group's portfolio in Q1 2026, its #543 holding.
  • Nemes Rush Group first reported a position in GSK in Q2 2023 and has held it in 10 quarters since.
  • Nemes Rush Group's GSK position peaked at $51.5K in Q1 2024.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Nemes Rush Group's 13F filing for Q1 2026, filed 21 Apr 2026.